Pila Pharma AB Total Liabilities

Latest as of June 2026: Skr748.00K SEK ≈ $80.50K USD

Pila Pharma AB total liabilities. Based on the latest financial reports, Pila Pharma AB (PILA) has total liabilities worth Skr748.00K SEK (≈ $80.50K USD) as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check PILA financial resilience to evaluate the company's liquid asset resilience ratio.

Total Liabilities of Pila Pharma AB (2015–2025)

Total liabilities of Pila Pharma AB from 2015 to 2025. This chart illustrates how Pila Pharma AB's total liabilities have evolved over time, based on quarterly financial data.

Pila Pharma AB Competitors by Total Liabilities

The table below lists competitors of Pila Pharma AB ranked by their total liabilities.

Company	Country	Total Liabilities
Energy Development Company Limited NSE:ENERGYDEV	India	Rs27.05 Million
JLEN Environmental Assets Group Ltd LSE:JLEN	UK	GBX1.80 Million
FD Technologies Plc LSE:FDP	UK	GBX149.47 Million
Tapaco Public Company Limited BK:TAPAC	Thailand	฿942.67 Million
Ekiz Kimya Sanayi ve Ticaret AS IS:EKIZ	Turkey	TL37.32 Million
Mahaka Media Tbk JK:ABBA	Indonesia	Rp354.46 Billion
ATAM VALVES ORD (BSE) NSE:ATAM	India	Rs-380.61 Million
Uma Exports Limited NSE:UMAEXPORTS	India	Rs1.87 Billion

Liability Composition Analysis (2015–2025)

This chart breaks down Pila Pharma AB's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see PILA current and non-current assets.

Liquidity & Leverage Metrics

Pila Pharma AB Total Liabilities Ratios Explained

Pila Pharma AB total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.

Metric	Value	Description
Current Ratio	4.81	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.05	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.04	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Pila Pharma AB's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Pila Pharma AB (2015–2025)

The table below shows the annual total liabilities of Pila Pharma AB from 2015 to 2025.

Year	Total Liabilities	Change
2025-12-31	Skr1.43 Million ≈ $154.32K	+48.91%
2024-12-31	Skr963.00K ≈ $103.63K	-46.33%
2023-12-31	Skr1.79 Million ≈ $193.09K	+32.22%
2022-12-31	Skr1.36 Million ≈ $146.03K	-10.42%
2021-12-31	Skr1.51 Million ≈ $163.01K	-22.20%
2020-12-31	Skr1.95 Million ≈ $209.53K	+301.72%
2019-12-31	Skr484.68K ≈ $52.16K	-41.04%
2018-12-31	Skr821.98K ≈ $88.46K	+46.42%
2017-12-31	Skr561.37K ≈ $60.41K	-12.93%
2016-12-31	Skr644.76K ≈ $69.39K	+162.19%
2015-12-31	Skr245.91K ≈ $26.46K	--

About Pila Pharma AB

ST:PILA Sweden Biotechnology

Market Cap

$6.93 Million

Skr64.41 Million SEK

Market Cap Rank

#27816 Global

#607 in Sweden

Share Price

Skr1.41

Change (1 day)

-9.62%

52-Week Range

Skr1.10 - Skr2.41

All Time High

Skr12.40